PROTOSOL

Country: Իսրայել

language: անգլերեն

source: Ministry of Health

active_ingredient:

APROTININ 10000 KIU / 1 ML

MAH:

KAMADA LTD

ATC_code:

B02AB01

pharmaceutical_form:

SOLUTION FOR INJECTION

administration_route:

I.V

manufactured_by:

KAMADA LTD ISRAEL

therapeutic_group:

APROTININ

therapeutic_indication:

Protosol is used in adults in the treatment and prophylaxis of disorders in which inhibition of proteolytic enzymes is indicated: For the early treatment of states of shock. For the prevention of postoperative or post-traumatic complications. To reduce major blood loss in patients undergoing surgery involving cardiopulmonary bypass.

authorization_date:

2008-12-01